Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPAREL vs Continuous Ropivacaine Block in Shoulder Replacement
NCT03474510Phase 4Withdrawn
- Sponsor
- TriHealth
- Start
- Mar 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in postoperative pain, sponsored by TriHealth. Planned start Mar 2018; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03474510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03474510.